Mineralocorticoids, hypertension, and cardiac fibrosis. - Wikidata - awgldk - TriplyDB

Mineralocorticoids, hypertension, and cardiac fibrosis.

Mineralocorticoids, hypertension, and cardiac fibrosis.

http://www.wikidata.org/entity/Q40337147

about

Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine The ubiquitous mineralocorticoid receptor: clinical implications Gene mutations that promote adrenal aldosterone production, sodium retention, and hypertension Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease Aldosterone as a determinant of cardiovascular and renal dysfunction Influence of aldosterone on collagen synthesis and proliferation of rat cardiac fibroblasts Mineralocorticoid receptor interaction with SP1 generates a new response element for pathophysiologically relevant gene expression Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury.Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study Aldosterone, a new appreciation of its role in heart failure.Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.New perspectives on the role of aldosterone excess in cardiovascular disease.Mineralocorticoids and cardiac fibrosis: the decade in review.Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis.Proinflammatory protein CARD9 is essential for infiltration of monocytic fibroblast precursors and cardiac fibrosis caused by Angiotensin II infusion.Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.Aldosterone receptor antagonists: biology and novel therapeutical applications.CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis.Aldosterone-induced inflammation in the rat heart : role of oxidative stress.Hypertensive heart disease: effects of lifestyle modifications and antihypertensive drug treatment.Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner.The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis.Classics in Cardiovascular Endocrinology: Aldosterone Action Beyond Electrolytes.Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome Role of aldosterone in the remnant kidney model in the rat.Impact of aldosterone-producing adenoma on cardiac structures in echocardiography.Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action.Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism.Effect of Spironolactone on Plasma Apelin-12 Levels in Patients with Chronic Systolic Heart Failure The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.Myocardial remodeling in low-renin hypertension: molecular pathways to cellular injury in relative aldosteronism Fibrosis in hypertensive heart disease: molecular pathways and cardioprotective strategies.From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.Pathogenesis and therapeutic implications of cardiorenal syndrome.The role of aldosterone in the metabolic syndrome.Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure.The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress

P2860

Q26827202-77805405-EE63-49F3-ACA4-20D9DB1F9896 Q26861721-1C66515C-DD87-454C-90B6-296FB3D203C0 Q26998925-27C8F8AD-94AD-4BA6-B6F2-5687A519AE19 Q28077454-06641278-13C0-480E-AA2A-0021D5C0EF88 Q28344356-ADFCC265-4CBA-4043-A757-F7D7807C5603 Q28346760-44D3B179-5BA0-46DA-A405-4F0B8A75C3EC Q30317783-1AC54817-F3A0-402C-8EF4-C7C7EC993065 Q33631594-F2D1566C-D80E-4DAB-86EE-9C88C0D9555C Q33829892-6C04764E-A99B-4903-9F20-EA74B4E001FA Q34041396-326A1FEB-9CFF-4083-BE3C-C565B56FC94E Q34061092-949AAA3B-89EB-4B15-B26D-16BC855A23C8 Q34068717-989AE923-1603-4E25-8472-EE7715ED4EDD Q34366011-6A2CCAF1-7C91-4923-94CF-F8E8F7475902 Q34570416-C4CD684A-7C1F-4088-A30D-EB42FBE7741E Q34778607-F1AE3137-A5E9-4F65-B490-A22F202D4412 Q35114753-704E71BA-40E5-4E70-9747-992AAAF3DEE0 Q35198525-BE582E27-C02A-4FAB-A8F1-55A4E660FA18 Q35605655-963F9D47-478D-4B84-B48E-AF8DAEE0091E Q35648733-C6626143-0117-4E19-950C-952F167B2E7C Q35747797-17D41C3E-46F0-4CCF-9E6D-46331AED3FAB Q35821934-E2CFE980-1A75-45DD-B1A3-AD125484B09E Q35963179-0BC4DB45-DE89-422B-936E-59EE7AADC1DA Q36238325-B7693547-0AB0-41D1-9A09-77AF3ACC3E07 Q36506452-02E9F846-7005-47A9-AEA4-FE2A77182D63 Q36521186-C6C0A1B5-5E72-4C1A-8B01-0E711F5CD612 Q36567326-535FF6F6-CBBF-4B3D-93C2-1D5AAD050FDE Q37358980-D37D4380-1F34-4E69-B2F5-A6D3939BA8E6 Q37365298-821C5165-C4E5-47ED-8B2A-CB198022AF1C Q37379344-88BDE468-0CF1-4712-B923-99BDCB70C458 Q37406166-B2F9E25E-8A6C-46F9-936E-F28D084ECA15 Q37430944-7F500F11-D927-4F3F-AD5E-8415E5FE4BF4 Q37448653-8EC308A0-310B-4B0F-A492-0F962E74CE98 Q37622571-2815C085-CE72-4A53-A10B-60D04F55ECEC Q37628826-D72F648E-8464-4E57-9665-4A1B746B6CBC Q37786169-0C402485-909B-4F14-96C5-BEBA351AA2BB Q37786549-2B8E65CD-FF30-4F3A-B777-382672AB0A8D Q37812022-08258739-C1F2-4A27-BE6A-BE6821BA4343 Q37833554-A8A54157-704F-46EC-90AC-6A4ED34D9315 Q37897992-4F4B6DFC-6475-4B5B-A5A1-64AA160CB538 Q37951441-00A490C8-DB4F-419E-AB4F-B4D87FE19D73

P2860

Mineralocorticoids, hypertension, and cardiac fibrosis.

http://www.wikidata.org/entity/Q40337147

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Mineralocorticoids, hypertension, and cardiac fibrosis.

@en

type

label

Mineralocorticoids, hypertension, and cardiac fibrosis.

@en

prefLabel

Mineralocorticoids, hypertension, and cardiac fibrosis.

@en

P1433

Q40337147-42F30B92-1AF4-476B-A174-80759177A4CB

P1476

Q40337147-69A8A64B-3120-4B91-9098-015ECE751F9D

P2093

Q40337147-4B8CDCA7-DD33-406C-AB2A-1D74398ABCD2

Q40337147-94EC3193-A471-452F-B0F4-46CBEC41BBB9

Q40337147-AD127BB8-F1A4-4EEB-A81E-086584D7524A

Q40337147-FC85567C-E089-4D43-B34E-967E53420A3B

P2860

Q40337147-0B893533-85CA-4865-A998-FA4B9DA99D0E

Q40337147-2B4952CE-9DFD-47DB-B74C-51F5C5233248

Q40337147-34AD9B67-B799-4A3A-8AE8-7247CA41A142

Q40337147-3896BC1B-EDE5-4BA2-8B94-BCEBD4B10C96

Q40337147-3BC73449-82ED-49EA-9312-F93A735AFCB8

Q40337147-8AF8189E-1D99-49C7-B65E-2AE64D6B7FEE

Q40337147-8DAF738B-95FF-497C-9D5D-104BEF197F13

Q40337147-9FF64B26-FC00-44C2-9A17-0CDA28FABEE6

Q40337147-C54545DD-B7F4-4EB2-BCD7-D9821E471A47

Q40337147-DC442F29-1C82-454F-B543-5AC98446700A

P304

Q40337147-85FC40B4-230B-4EE7-B54F-69F7B10BDEEA

P31

Q40337147-B2D33BD7-4159-406E-B839-1C28668DE544

P356

Q40337147-0BACDC59-0287-45ED-BBD6-BA1045FC2CCA

P407

Q40337147-A063C367-52FC-4307-B5CE-D1C982E2A9C8

P433

Q40337147-CEEDEF0B-7551-4180-A7A9-33EE64324AD3

P478

Q40337147-DD033EB0-3D14-480C-B585-CCD06AC1057D

P577

Q40337147-EB4E0CC1-82F0-412F-8471-724DB5A2C6CA

P698

Q40337147-7F3C1568-9329-45D4-A26B-E37C22228DE3

P932

Q40337147-2180D662-7C6A-45DF-A045-6C565ED7A906

P356

P1433

Journal of Clinical Investigation

P1476

Mineralocorticoids, hypertension, and cardiac fibrosis.

@en

P2093

Dilley R

http://www.w3.org/2001/XMLSchema#string

Fullerton M

http://www.w3.org/2001/XMLSchema#string

Funder J

http://www.w3.org/2001/XMLSchema#string

Young M

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

What is the role of the central nervous system in mineralocorticoid hypertension?

Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.

Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.

Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.

Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells.

High-affinity aldosterone binding in rat liver--a re-evaluation.

ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension.

Aldosterone effects on salt appetite in adrenalectomized rats.

P304

2578-2583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI117269

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1994-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8200995

http://www.w3.org/2001/XMLSchema#string

P932

294488

http://www.w3.org/2001/XMLSchema#string